Next Century Growth Investors LLC Ligand Pharmaceuticals Inc Transaction History

Next Century Growth Investors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$86.25 - $120.16 $3.56 Million - $4.97 Million	-41,322 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$107.38 - $129.34 $114,144 - $137,488	-1,063 Reduced 2.51%	41,322 $4.72 Million
Q1 2019 May 14, 2019	SELL	$105.93 - $142.47 $2.25 Million - $3.02 Million	-21,223 Reduced 33.37%	42,385 $5.33 Million
Q4 2018 Feb 14, 2019	BUY	$128.36 - $272.13 $2.34 Million - $4.97 Million	18,250 Added 40.24%	63,608 $8.63 Million
Q3 2018 Nov 14, 2018	SELL	$211.18 - $274.49 $1.45 Million - $1.88 Million	-6,855 Reduced 13.13%	45,358 $12.5 Million
Q2 2018 Aug 14, 2018	SELL	$150.77 - $207.98 $576,846 - $795,731	-3,826 Reduced 6.83%	52,213 $10.8 Million
Q1 2018 May 14, 2018	SELL	$138.63 - $182.62 $3.82 Million - $5.04 Million	-27,573 Reduced 32.98%	56,039 $9.26 Million
Q4 2017 Feb 13, 2018	SELL	$128.36 - $147.04 $839,474 - $961,641	-6,540 Reduced 7.25%	83,612 $11.4 Million
Q3 2017 Nov 14, 2017	SELL	$120.91 - $137.94 $3.61 Million - $4.12 Million	-29,886 Reduced 24.9%	90,152 $12.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	120,038	120,038 $14.6 Million

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.07B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Next Century Growth Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Next Century Growth Investors LLC with notifications on news.